Search results

Found 5,000 pages
AUTHOR: Kevin Grogan

Your search yielded no results

  • Check if your spelling is correct.
  • Remove quotes around phrases to search for each word individually. bike shed will often show more results than "bike shed".
  • Consider loosening your query with OR. bike OR shed will often show more results than bike shed.

Sanofi and BI ink biologics manufacturing deal

Sanofi has signed up Boehringer Ingelheim as its partner to manufacture monoclonal antibodies. - News - PharmaTimes

by Kevin Grogan

www.pharmatimes.com/news/sanofi_and_bi_ink_biologics_manufacturing_deal_970872

Shire extends offer for ViroPharma again

Shire has extended its tender offer to buy ViroPharma for a second time, now expiring on midnight January 23. - News - PharmaTimes

by Kevin Grogan

www.pharmatimes.com/news/shire_extends_offer_for_viropharma_again_1001342

Teva gets FDA OK for generic Combivir

Teva Pharmaceutical Industries has been granted the first approval to market a generic version of the HIV drug Combivir. - News - PharmaTimes

by Kevin Grogan

www.pharmatimes.com/news/teva_gets_fda_ok_for_generic_combivir_980970

Nestle pact with stem cell biotech CDI

Food giant Nestle has linked up with USA-based stem cell specialist Cellular Dynamics International. - News - PharmaTimes

by Kevin Grogan

www.pharmatimes.com/news/nestle_pact_with_stem_cell_biotech_cdi_1001327

FDA approves Novartis eye drops Pazeo

Novartis unit Alcon says the US Food and Drug Administration has approved Pazeo for the treatment of ocular itching associated with allergic conjunctivitis. - News - PharmaTimes

by Kevin Grogan

www.pharmatimes.com/news/fda_approves_novartis_eye_drops_pazeo_970966

XTL buys Teva's stake in Proteologics

XTL Biopharmaceuticals has bought a major stake in fellow Israeli drugmaker Proteologics from Teva Pharmaceutical Industries. - News - PharmaTimes

by Kevin Grogan

www.pharmatimes.com/news/xtl_buys_tevas_stake_in_proteologics_976154

Earlier start for new GSK chairman Hampton

Sir Philip Hampton will take over from Sir Christopher Gent as chairman of GlaxoSmithKline on May 7, nearly four months earlier than expected. - News - PharmaTimes

by Kevin Grogan

www.pharmatimes.com/news/earlier_start_for_new_gsk_chairman_hampton_971116

Recordati acquires Tunisia's Opalia

Recordati is buying a 90% stake in Opalia Pharma of Tunisia in a deal valued at 80 million dinar, or around 37 million euros. - News - PharmaTimes

by Kevin Grogan

www.pharmatimes.com/news/recordati_acquires_tunisias_opalia_1005440

Europe approves Bayer's Jaydess

Bayer has been given the green light by Europe's regulator to market its new long-term contraceptive Jaydess which provides prevention of pregnancy for up to three years. - News - PharmaTimes

by Kevin Grogan

www.pharmatimes.com/news/europe_approves_bayers_jaydess_976096

SMC backs Alimera eye drug

Scottish diabetics with a condition that causes blurred or double vision will be cheered by the news that Alimera Sciences' Iluvien has been backed by the country's cost watchdog. - News - PharmaTimes

by Kevin Grogan

www.pharmatimes.com/news/smc_backs_alimera_eye_drug_1001518

Latest jobs

View all

What job are you looking for?

This field is required.

Download our apps

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Download